Tag: metastatic neuroendocrine tumors
Lexicon’s Xermelo gets FDA approval to treat carcinoid syndrome diarrhea
Lexicon Pharmaceuticals’ oral drug Xermelo (telotristat ethyl) 250mg has been approved in combination with somatostatin analog (SSA) therapy by the US Food and Drug Administration ... Read More